Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.

I add two companies to our Dividend Income Accelerator Portfolio each month. Find out why I have added Novo Nordisk (NVO) and ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

A miracle drug just wiped out WeightWatchers International’s (WW) 60-year empire. Here’s how Ozempic disrupted the weight ...

For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, 10-year data from the ...

South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...

A pragmatic approach to streamlining technology and innovating processes will help advance clinical data management.

Equity Insider News Commentary ? The World Economic Forum recently spotlighted five healthcare breakthroughs, and at the top of the list was artificial intelligence. From surgical precision tools to ...

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...